Klobuchar urges drugmakers to remove patents FTC calls improper and inaccurate; Bernie Sanders proposes subpoenas of CEOs of J&J, Merck on drug prices

Taking stock of the drug industry, from the lab to the medicine chest

January 18, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

J. Scott Applewhite/AP STAT+ | Klobuchar urges drugmakers to remove patents FTC calls improper and inaccurate The move comes in response to complaints that drugmakers too often pursue inconsequential patents that do not reflect true innovation. By Ed Silverman Bernie Sanders proposes subpoenas of CEOs of J&J, Merck on drug prices Bernie Sanders is hoping to subpoena the CEOs of J&J and Merck to testify in Congress about high drug prices in a highly unusual step. By Rachel Cohrs STAT+ | How digital therapeutics companies are improvising when insurance coverage isn't guaranteed Health insurers have been slow to cover novel digital therapeutics, forcing the companies behind them to improvise to stay in business. By Mario Aguilar

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser